CLINUVEL PHARMACEUTICALS LIMITED (CUVL) Net margin 2024–2026
CLINUVEL PHARMACEUTICALS LIMITED (CUVL) net profit margin by fiscal year — reported net income divided by reported revenue.
36.0%FY2026 · since FY2024: 40.3% → 36.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 36.0% | -1.8 pp |
| FY2025 | 37.8% | -2.5 pp |
| FY2024 | 40.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CUVL financial trends
CUVL RevenueCUVL Net incomeCUVL Gross profitCUVL Gross marginCUVL Operating incomeCUVL Operating marginCUVL Operating cash flowCUVL Free cash flowCUVL Capital expendituresCUVL Return on equityCUVL Stock buybacksCUVL Dividends paidCUVL Total assetsCUVL Total liabilitiesCUVL Shareholders’ equityCUVL overview →